Edition:
United Kingdom

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,535.20GBp
4:52pm BST
Change (% chg)

12.40 (+0.81%)
Prev Close
1,522.80
Open
1,524.60
Day's High
1,537.40
Day's Low
1,516.20
Volume
5,879,208
Avg. Vol
8,052,115
52-wk High
1,634.48
52-wk Low
1,235.20

Select another date:

Tue, Sep 18 2018

Photo

GSK grabs new drug development head from Boehringer

LONDON GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

GSK grabs new drug development head from Boehringer

LONDON GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

GSK grabs new drug development head from Boehringer

LONDON, Sept 18 GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development as the company reshapes its research strategy, a spokesman for the British group said on Tuesday.

GSK says U.S. FDA wants more information on pulmonary drug

LONDON GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD).

GSK says U.S. FDA wants more information on pulmonary drug

LONDON GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD).

GSK says U.S. FDA wants more information on pulmonary drug

LONDON, Sept 7 GlaxoSmithKline said on Friday that U.S. health authorities had asked for more information about its Nucala drug for use in combating chronic obstructive pulmonary disease (COPD).

Drugmaker GSK to eliminate 650 U.S. jobs

British drugmaker GlaxoSmithKline Plc said on Wednesday it would cut about 650 positions in the United States related to a global restructuring program it announced in July.

Drugmaker GSK to eliminate 650 U.S. jobs

British drugmaker GlaxoSmithKline Plc said on Wednesday it would cut about 650 positions in the United States related to a global restructuring program it announced in July.

Drugmaker GSK to eliminate 650 U.S. jobs

Sept 5 British drugmaker GlaxoSmithKline Plc said on Wednesday it would cut about 650 positions in the United States related to a global restructuring program it announced in July.

GSK seeks mid-Sept bids for $4 billion Indian Horlicks unit -sources

LONDON GlaxoSmithKline is seeking initial bids by mid-September for its India-focused Horlicks health nutrition business, which is expected to fetch more than $4 billion (£3.1 billion), two people familiar with the situation said on Tuesday.

Select another date: